scholarly journals Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial

2019 ◽  
Vol 11 (3) ◽  
pp. 653-661 ◽  
Author(s):  
Hajime Yamakage ◽  
Masashi Tanaka ◽  
Takayuki Inoue ◽  
Shinji Odori ◽  
Toru Kusakabe ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Growth Factor ◽  
Controlled Trial ◽  
Japanese Patients ◽  
Serum Levels ◽  
Fibroblast Growth Factor 21 ◽  
Fibroblast Growth ◽  
Randomized Controlled

scholarly journals Randomized controlled trial of single-agent glimepiride and pioglitazone in Japanese patients with type 2 diabetes: A comparative study

2011 ◽  
Vol 2 (5) ◽  
pp. 391-398 ◽  
Author(s):  
Nobuyuki Shihara ◽  
Masafumi Kitaoka ◽  
Nobuya Inagaki ◽  
Takashi Kadowaki ◽  
Seisuke Koumoto ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Comparative Study ◽  
Controlled Trial ◽  
Single Agent ◽  
Japanese Patients ◽  
Randomized Controlled

scholarly journals Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial

2019 ◽  
Vol 10 (3) ◽  
pp. 1019-1027 ◽  
Author(s):  
Megumi Inoue ◽  
Masanari Shiramoto ◽  
Tomonori Oura ◽  
Risa Nasu ◽  
Masako Nakano ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Japanese Patients ◽  
Glucose Levels ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document